Oncothyreon Inc (NASDAQ:ONTY) announced the appointment of Steven P. James to its board of directors. On Thursday shares of Oncothyreon Inc (NASDAQ:ONTY) closed at $1.61.
Soft drinks giants PepsiCo and Coca-Cola Company (NYSE:KO) Hellenic have announced that they are to halt production at key plants in Russia in connection with the ongoing financial crisis. Meanwhile, Coca-Cola Hellenic, the Coca-Cola bottler, has already closed its plant in Nizhny Novgorod, Yevgeniya Mogilyova, communications manager, told the TASS news agency on March 2. The Coca-Cola Company (NYSE:KO) in last trading activity decreased -0.24% to close at $42.40. Company weekly performance is -0.14% while its quarterly performance stands at -4.80%. The Coca-Cola Company (NYSE:KO) is -5.78% away from its 52 week high.
South Jersey Industries, Inc. (NYSE:SJI) will begin trading ex-dividend on March 06, 2015. A cash dividend payment of $0.5025 per share is scheduled to be paid on April 02, 2015. Shareholders who purchased SJI prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 6.35% increase over the same period a year ago. On last trading day South Jersey Industries, Inc. (NYSE:SJI) decreased -0.02% to close at $54.68. Its volatility for the week is 1.91% while volatility for the month is 2.06%. SJI’s sales growth for past 5 years was -5.30% and its EPS growth for past 5 years was -0.20%. South Jersey Industries, Inc. (NYSE:SJI) monthly performance is -8.38%.
On February 26, 2015 Tumi Holdings, Inc. (NYSE:TUMI) announced its financial results for the fourth quarter and full year ended December 31, 2014. Net sales increased 11.1% to $163.8 million from $147.4 million in the fourth quarter ended December 31, 2013. Operating income increased 14.1% to $36.9 million from $32.4 million in the fourth quarter of 2013. Operating income margin was 22.5% compared to 22.0% in the fourth quarter of 2013.Tumi Holdings, Inc. (NYSE:TUMI) has 29.31% insider ownership while its institutional ownership stands at 79.30%. In last trading activity company’s stock closed at $22.95.
AbbVie Inc is to buy Pharmacyclics Inc. (NASDAQ:PCYC) for about $21 billion, giving it access to what is expected to be one of the world’s top-selling cancer drugs and expanding its reach in the profitable oncology field. On last trading day Pharmacyclics Inc. (NASDAQ:PCYC) moved up 10.30% to close at $254.22. Its volatility for the week is 4.18% while volatility for the month is 5.20%. PCYC’s sales growth for past 5 years was 139.30% and its EPS growth for past 5 years was 40.90%. Pharmacyclics Inc. (NASDAQ:PCYC) monthly performance is 57.68%.